Joseph M. Kahwaji - Publications

Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter study.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: December 30, 2024

Safety and Efficacy of Liraglutide and Semaglutide in Kidney Transplant Recipients.

Journal: Kidney360

Published: November 12, 2024

Pretransplant cardiac stress testing and transplant wait time in kidney transplantation candidates.

Journal: Open heart

Published: May 05, 2024

Bisphosphonate Use after Kidney Transplantation Is Associated with Lower Fracture Risk.

Journal: Clinical journal of the American Society of Nephrology : CJASN

Published: March 08, 2024

Viral-specific cytotoxic T-cell responses in HLA-sensitized kidney transplant patients maintained on everolimus and low-dose tacrolimus.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: October 13, 2021

Belatacept Conversion Protocols and Outcomes in Kidney Transplant Recipients.

Journal: Transplantation proceedings

Published: June 30, 2020

Plasma Exosomes From HLA-Sensitized Kidney Transplant Recipients Contain mRNA Transcripts Which Predict Development of Antibody-Mediated Rejection.

Journal: Transplantation

Published: May 31, 2017

Impact of Desensitization on Antiviral Immunity in HLA-Sensitized Kidney Transplant Recipients.

Journal: Journal of immunology research

Published: October 17, 2016

Assessment of Tocilizumab (Anti-Interleukin-6 Receptor Monoclonal) as a Potential Treatment for Chronic Antibody-Mediated Rejection and Transplant Glomerulopathy in HLA-Sensitized Renal Allograft Recipients.

Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons

Published: September 14, 2016

Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.

Journal: Kidney international

Published: July 05, 2016

Risk factors associated with the development of histocompatibility leukocyte antigen sensitization.

Journal: Current opinion in organ transplantation

Published: June 04, 2016

Six-year outcomes in broadly HLA-sensitized living donor transplant recipients desensitized with intravenous immunoglobulin and rituximab.

Journal: Transplant international : official journal of the European Society for Organ Transplantation

Published: February 26, 2016